168 related articles for article (PubMed ID: 31887854)
1. Effects of the online computerized cognitive training program BEYNEX on the cognitive tests of individuals with subjective cognitive impairment and Alzheimer’s disease on rivastigmine therapy.
Çinar N; Şahiner TAH
Turk J Med Sci; 2020 Feb; 50(1):231-238. PubMed ID: 31887854
[TBL] [Abstract][Full Text] [Related]
2. The effects of an 8-week computerized cognitive training program in older adults: a study protocol for a randomized controlled trial.
Ten Brinke LF; Best JR; Crockett RA; Liu-Ambrose T
BMC Geriatr; 2018 Jan; 18(1):31. PubMed ID: 29378515
[TBL] [Abstract][Full Text] [Related]
3. Rivastigmine transdermal patch and capsule in Alzheimer's disease: influence of disease stage on response to therapy.
Farlow MR; Grossberg GT; Meng X; Olin J; Somogyi M
Int J Geriatr Psychiatry; 2011 Dec; 26(12):1236-43. PubMed ID: 22068922
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of rivastigmine transdermal therapy on low food intake in patients with Alzheimer's disease: The Attitude Towards Food Consumption in Alzheimer's Disease Patients Revive with Rivastigmine Effects study.
Tsuno N; Mori T; Ishikawa I; Bando N; Park H; Matsumoto Y; Mori I; Tanaka M; Hirano T; Nakamura Y
Geriatr Gerontol Int; 2019 Jul; 19(7):571-576. PubMed ID: 30864298
[TBL] [Abstract][Full Text] [Related]
5. A pilot randomized controlled trial evaluating an integrated treatment of rivastigmine transdermal patch and cognitive stimulation in patients with Alzheimer's disease.
D'Onofrio G; Sancarlo D; Addante F; Ciccone F; Cascavilla L; Paris F; Elia AC; Nuzzaci C; Picoco M; Greco A; Panza F; Pilotto A
Int J Geriatr Psychiatry; 2015 Sep; 30(9):965-75. PubMed ID: 25504466
[TBL] [Abstract][Full Text] [Related]
6. Effect of cholinergic treatment depends on cholinergic integrity in early Alzheimer's disease.
Richter N; Beckers N; Onur OA; Dietlein M; Tittgemeyer M; Kracht L; Neumaier B; Fink GR; Kukolja J
Brain; 2018 Mar; 141(3):903-915. PubMed ID: 29309600
[TBL] [Abstract][Full Text] [Related]
7. Mild versus moderate stages of Alzheimer's disease: three-year outcomes in a routine clinical setting of cholinesterase inhibitor therapy.
Wattmo C; Minthon L; Wallin ÅK
Alzheimers Res Ther; 2016 Feb; 8():7. PubMed ID: 26883213
[TBL] [Abstract][Full Text] [Related]
8. Short-term computerized cognitive training does not improve cognition compared to an active control in non-demented adults aged 80 years and above.
West RK; Rabin LA; Silverman JM; Moshier E; Sano M; Beeri MS
Int Psychogeriatr; 2020 Jan; 32(1):65-73. PubMed ID: 30968798
[TBL] [Abstract][Full Text] [Related]
9. Selective Ability of Some CANTAB Battery Test Measures to Detect Cognitive Response to a Single Dose of Donepezil in Alzheimer Disease.
Kuzmickienė J; Kaubrys G
Med Sci Monit; 2015 Aug; 21():2572-82. PubMed ID: 26336931
[TBL] [Abstract][Full Text] [Related]
10. Improvement of spontaneous speech in early stage Alzheimer's with rivastigmine.
Visch Brink EG; Van Rhee Temme W; Rietveld T; Krulder JW; Van Harskamp F; Van der Cammen TJ
J Nutr Health Aging; 2009 Jan; 13(1):34-8. PubMed ID: 19151906
[TBL] [Abstract][Full Text] [Related]
11. Computerized Cognitive Training in Older Adults With Mild Cognitive Impairment or Dementia: A Systematic Review and Meta-Analysis.
Hill NT; Mowszowski L; Naismith SL; Chadwick VL; Valenzuela M; Lampit A
Am J Psychiatry; 2017 Apr; 174(4):329-340. PubMed ID: 27838936
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and Concurrent Validity of Computerized Brain Training Based on Everyday Living (BTEL) Based on Instrumental Activities of Living for Cognitively Healthy Old Individuals: A Preliminary Study.
Asada T; Tanaka M; Araki W; Jon Lebowitz A; Kakuma T
J Alzheimers Dis; 2024; 99(2):549-558. PubMed ID: 38701140
[TBL] [Abstract][Full Text] [Related]
13. Cerebral White Matter Changes on Therapeutic Response to Rivastigmine in Alzheimer's Disease.
Ho BL; Kao YH; Chou MC; Yang YH
J Alzheimers Dis; 2016 Aug; 54(1):351-7. PubMed ID: 27567838
[TBL] [Abstract][Full Text] [Related]
14. The Effects of Computerized Cognitive Training With and Without Physical Exercise on Cognitive Function in Older Adults: An 8-Week Randomized Controlled Trial.
Ten Brinke LF; Best JR; Chan JLC; Ghag C; Erickson KI; Handy TC; Liu-Ambrose T
J Gerontol A Biol Sci Med Sci; 2020 Mar; 75(4):755-763. PubMed ID: 31054254
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of higher-dose 13.3 mg/24 h (15 cm2) rivastigmine patch on the Alzheimer's Disease Assessment Scale-cognitive subscale: domain and individual item analysis.
Alva G; Isaacson R; Sadowsky C; Grossberg G; Meng X; Somogyi M
Int J Geriatr Psychiatry; 2014 Sep; 29(9):920-7. PubMed ID: 24549933
[TBL] [Abstract][Full Text] [Related]
16. Montreal Cognitive Assessment Memory Index Score (MoCA-MIS) as a predictor of conversion from mild cognitive impairment to Alzheimer's disease.
Julayanont P; Brousseau M; Chertkow H; Phillips N; Nasreddine ZS
J Am Geriatr Soc; 2014 Apr; 62(4):679-84. PubMed ID: 24635004
[TBL] [Abstract][Full Text] [Related]
17. The CITIRIVAD Study: CITIcoline plus RIVAstigmine in Elderly Patients Affected with Dementia Study.
Castagna A; Cotroneo AM; Ruotolo G; Gareri P
Clin Drug Investig; 2016 Dec; 36(12):1059-1065. PubMed ID: 27587069
[TBL] [Abstract][Full Text] [Related]
18. Long-term effectiveness of rivastigmine patch or capsule for mild-to-severe Alzheimer's disease: a meta-analysis.
Su J; Liu Y; Liu Y; Ren L
Expert Rev Neurother; 2015; 15(9):1093-103. PubMed ID: 26289489
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
